Honz Pharmaceutical Co., Ltd. (SHE:300086)
9.57
+0.15 (1.59%)
Feb 4, 2026, 3:05 PM CST
Honz Pharmaceutical Revenue
Honz Pharmaceutical had revenue of 93.93M CNY in the quarter ending September 30, 2025, a decrease of -34.59%. This brings the company's revenue in the last twelve months to 435.39M, down -33.19% year-over-year. In the year 2024, Honz Pharmaceutical had annual revenue of 472.82M, down -36.07%.
Revenue (ttm)
435.39M
Revenue Growth
-33.19%
P/S Ratio
10.00
Revenue / Employee
660.68K
Employees
659
Market Cap
4.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 472.82M | -266.75M | -36.07% |
| Dec 31, 2023 | 739.57M | 203.82M | 38.05% |
| Jan 1, 2023 | 535.75M | -300.82M | -35.96% |
| Jan 1, 2022 | 836.57M | -85.08M | -9.23% |
| Dec 31, 2020 | 921.64M | -86.79M | -8.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tianjin Tianyao Pharmaceuticals | 2.87B |
| Jinhe Biotechnology CO., LTD. | 2.75B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Yabao Pharmaceutical Group | 2.27B |
| Ningbo Menovo Pharmaceutical | 1.54B |
| Huaren Pharmaceutical | 1.26B |
| LanZhou Foci Pharmaceutical | 895.75M |
| Shandong Wohua Pharmaceutical | 816.95M |